A. S. Arebee, “CRISPR Gene-Editing Therapies for Sickle Cell Disease and Beta- Thalassemia: Clinical Outcomes, Risks and Safety Profiles. A Systematic Review”, ljmas, vol. 3, no. 4, pp. 102–108, Dec. 2025.